Publisher Correction to: J Cannabis Res 2, 36 (2020)
https://doi.org/10.1186/s42238-020-00045-x
Following publication of the original article (Wallace et al. 2020), the authors reported that the article had published with errors in some of the tables; data had been erroneously omitted from Tables 1, 2 and 6, and these tables had been incorrectly formatted.
Table 1.
Human Patients (N = 313) | Dog Patients (N = 204) | ||
---|---|---|---|
Primary Cause of Chronic Pain | Primary Cause of Chronic Pain | ||
Chronic Back Pain | 48%(149) | Chronic Back Pain | 22% (45) |
Degenerative Joint Disease | 17% (54) | Degenerative Joint Disease | 45% (91) |
Mouth Pain or Headache | 17% (52) | Mouth Pain from Dental Disease | 7% (14) |
Other | 18% (58) | Other | 26% (54) |
χ2 (3, N = 571) = 67.22, p < .001 | |||
Length of Time with Chronic Pain | Length of Time with Chronic Pain | ||
< 1 year | 18% (55) | < 1 year | 36% (74) |
1-5 years | 47% (146) | 1-3 years | 55% (112) |
> 5 years | 35% (108) | > 3 years | 9% (18) |
χ2 (2, N = 513) = 52.26, p < .001 |
Table 2.
Human Patients (N =313) | Dog Patients (N = 204) | ||
---|---|---|---|
Type of Cannabis Product Used a | Types of Cannabis Product Used a | ||
Marijuana/Cannabis (THC > 0.3%) | 76% (237) | Marijuana/Cannabis (THC > 0.3%) | 26% (53) |
Hemp Isolate (THC < 0.3%) | 49% (152) | Hemp Isolate (THC < 0.3%) | 44% (89) |
CBD/Hemp Broad or Full Spectrum | 36% (113) | CBD/Hemp Broad or Full Spectrum | 42% (88) |
Not Sure | 3% (9) | Not Sure | 11% (22) |
Most Frequent Way of Obtaining Cannabis | Most Frequent Way of Obtaining Cannabis | ||
Given by Friend or Family | 33% (102) | Given by Friend or Family | 11% (22) |
Dispensary or Store | 30% (92) | Dispensary or Store | 25% (50) |
Natural/Health Store/Service | 12% (40) | Natural/Health Store/Service | 25% (50) |
Online Source | 12% (36) | Online Source | 34% (68) |
Other | 13% (43) | Other | 5% (14) |
χ2 (4, N = 517) = 69.87, p < .001 |
aParticipants could select more than one type of cannabis product
Table 6.
Human Patients (N = 313) | Dog Patients (N = 204) | ||
---|---|---|---|
Type of Cannabis Product Used a | Types of Cannabis Product Used a | ||
Marijuana/Cannabis (THC > 0.3%) | 88% (199) | Marijuana/Cannabis (THC > 0.3%) | 94% (45) |
Hemp Isolate (THC < 0.3%) | 83% (120) | Hemp Isolate (THC < 0.3%) | 76% (68) |
CBD/Hemp Broad or Full Spectrum | 90% (99) | CBD/Hemp Broad or Full Spectrum | 87% (75) |
Not Sure | 67% (6) | Not Sure | 68% (15) |
Most Frequent Way of Obtaining Cannabis | Most Frequent Way of Obtaining Cannabis | ||
Given by Friend or Family | 86% (88) | Given by Friend or Family | 77% (17) |
Dispensary or Store | 85% (78) | Dispensary or Store | 84% (42) |
Natural/Health Store/Service | 90% (36) | Natural/Health Store/Service | 84% (42) |
Online Source | 78% (36) | Online Source | 82% (56) |
Other | 80% (20) | Other | 63% (9) |
aParticipants could select more than one type of cannabis product
The original article has since been updated to correct the tables.
Furthermore, please find the (corrected) tables in this correction for reference.
The publisher apologizes for this error and any inconvenience caused.
Reference
- Wallace JE, Kogan LR, Carr ECJ, et al. Motivations and expectations for using cannabis products to treat pain in humans and dogs: a mixed methods study. J Cannabis Res. 2020;2:36. doi: 10.1186/s42238-020-00045-x. [DOI] [PMC free article] [PubMed] [Google Scholar]